The global oral mucositis treatment market size accounted for USD 1.85 billion in 2024 and is expected to exceed around USD 3.72 billion by 2034, growing at a CAGR of 7.20% from 2025 to 2034. The growth of the oral mucositis treatment market is attributed to the increasing incidence of cancer, the development of cancer treatments, awareness, and the need for the management of oral complications due to cancer treatments.
The global vitamin B3 market size accounted for USD 386.22 million in 2024 and is expected to exceed USD 481.52 million by 2034, growing at a CAGR of 2.23% from 2025 to 2034. The increased demand for nicotinic acid in condition treatment solutions is driving the growth of the global vitamin B3 market. The growing adoption of vitamin B3 to treat cardiovascular disease is projected to further enhance the market in the upcoming period.
The global scleroderma therapeutics market size was calculated at USD 2.61 billion in 2024 and is predicted to reach around USD 4.28 billion by 2034, expanding at a CAGR of 5.07% from 2025 to 2034. The demand for effective treatment solutions is driving the growth of the global scleroderma therapeutics market. The prevalence of rare diseases like scleroderma is increasing, and R&D activities are increasing, making the market more expanded. Additionally, government support and initiatives for R&D firms and healthcare are significantly fueling market expansion.
The global oral cancer rapid test kit market size was accounted for USD 2.26 billion in 2024 and is expected to exceed around USD 3.76 billion by 2034, growing at a CAGR of 5.21% from 2025 to 2034. The increased public awareness for early detection of oral cancer is the key factor driving the growth of the global oral cancer rapid test kit market. The easy accessibility of kits in retail stores and online platforms is expanding the market growth.
The global targeted DNA RNA sequencing market size accounted for USD 11.96 billion in 2024 and is expected to exceed USD 70.55 billion by 2034, growing at a CAGR of 19.42% from 2025 to 2034. The demand for the targeted DNA RNA sequencing market is driven by the rising need for genetic data based on the specific region which helps in innovating personalized medications to the patients.
The global neuroendocrine tumor treatment market size accounted for USD 2.71 billion in 2024 and is expected to exceed around USD 4.89 billion by 2034, growing at a CAGR of 6.09% from 2025 to 2034. Growing awareness of neuroendocrine tumors and the importance of early detection are driving the growth of the neuroendocrine tumor treatment market. The growing demand for personalized medicines is contributing to the market expansions. Moreover, growing research and development activities are likely to boost the market expansion in the forecast period.
The global physical therapy software market size accounted for USD 1.39 billion in 2024 and is expected to exceed around USD 3.82 billion by 2034, growing at a CAGR of 10.63% from 2025 to 2034. The physical therapy software market growth is attributed to the increasing adoption of digital health solutions and the rising demand for personalized, remote rehabilitation services.
The global digital thermometer market size was calculated at USD 780.12 million in 2024 and is predicted to reach around USD 1,936.85 million by 2034, expanding at a CAGR of 9.52% from 2025 to 2034. The industry is driven by the rise in demand for mercury-free thermometers. In addition, the increasing geriatric population, increasing continuous growth of telehealth services, and convenience and ease of use offered by digital thermometers are expected to drive the growth of the digital thermometer market.
The global toxicology testing services market size was calculated at USD 39.05 billion in 2024 and is predicted to reach around USD 67.34 billion by 2034, expanding at a CAGR of 5.60% from 2025 to 2034. The increasing demand for the early-stage diagnostics testing method in the drug development process more sustainably is driving the growth of the toxicology testing services market.
The global liver fibrosis treatment market size accounted for USD 18.32 billion in 2024 and is expected to exceed USD 52.26 billion by 2034, growing at a CAGR of 11.05% from 2025 to 2034. The liver fibrosis treatment market is growing due to increasing disease incidence such as NAFLD, hepatitis, and cirrhosis. These include improved drug innovation and enhanced diagnosis.
The global laboratory robotics market size accounted for USD 2.56 billion in 2024 and is expected to exceed around USD 5.09 billion by 2034, growing at a CAGR of 7.12% from 2025 to 2034. The growing demand for efficient laboratory operations is the key factor driving the laboratory robotics market growth. Also, the increasing adoption of robotic systems in the medical industry coupled with the advancements In technology can fuel market growth further.
The global stomach cancer treatment market size was evaluated at USD 5.40 billion in 2024 and is predicted to reach around USD 17.60 billion by 2034, expanding at a CAGR of 12.54% from 2025 to 2034. The demand for the stomach cancer treatment market is increasing due to the rise in global cancer incidences. This promotes the adoption of technologies that can help in providing therapies to patients.
The global rosacea treatment market size was calculated at USD 2.12 billion in 2024 and is anticipated to reach around USD 4.23 billion by 2034, expanding at a CAGR of 7.14% from 2025 to 2034. The increasing number of skin diseases such as rosacea in the population drives the growth of the rosacea treatment market as the demand for effective diagnostics and disease management increases.
The global inhaled nitric oxide delivery systems market size accounted for USD 360.81 million in 2024 and is expected to exceed around USD 562.47 million by 2034, growing at a CAGR of 4.54% from 2025 to 2034. The rising demand for rapid drug delivery devices with the ease in use and convenient for the patient with any types of respiratory disease are contributed in the growth of the market.
The global fitness platforms for disabled market size was calculated at USD 3.35 billion in 2024 and is predicted to reach around USD 24.96 billion by 2034, expanding at a CAGR of 22.24% from 2025 to 2034. The fitness platforms for disabled market are driven by the rising awareness of the importance of physical activity and fitness for individuals with disabilities.
The global surgical imaging market size was calculated at USD 5.44 billion in 2024 and is predicted to reach around USD 9.60 billion by 2034, expanding at a CAGR of 5.84% from 2025 to 2034. The global surgical imaging market growth is attributed to the growing geriatric population and rising prevalence of chronic diseases during the forecast period.
The global bronchial biopsy devices market size was calculated at USD 673.38 million in 2024 and is predicted to reach around USD 1,377.57 million by 2034, expanding at a CAGR of 7.42% from 2025 to 2034. The bronchial biopsy devices market is growing because of the rising incidence of respiratory illnesses and lung cancer, as well as improved technologies, an increasing number of elderly, and growing awareness of people towards health, which also contributes to growth in demand.
The global veterinary telehealth market size was calculated at USD 306.75 million in 2024 and is predicted to reach around USD 1,955.44 million by 2034, expanding at a CAGR of 20.35% from 2025 to 2034. The veterinary telehealth market is driven by the increasing demand for convenient and accessible pet care services.
The global veterinary lasers market size is estimated to surpass around USD 727.36 million by 2034 increasing from USD 314.67 million in 2024, growing at a CAGR of 8.74%. The growing demand to treat several conditions in pets, such as injuries, diseases, and arthritis, is growing the requirement for the veterinary lasers market, which focuses on reducing pet’s inflammation and pain and improving wound healing.
The global tele-intensive care unit market size was accounted for USD 4.27 billion in 2024 and is expected to exceed around USD 17.44 billion by 2034, growing at a notable CAGR of 15.11% from 2025 to 2034. The rising number of challenges in the ICU healthcare system can be resolved with the help of audiovisual technology and electronic medical records, contributing to the expansion of the tele-intensive care unit market.
The global healthcare data monetization solutions market size was calculated at USD 921.04 million in 2024 and is predicted to reach around USD 4,077.14 million by 2034, expanding at a CAGR of 16.04% from 2025 to 2034. The growing need to leverage patient information, medical records, and clinical insights, which help generate revenue or value for healthcare organizations, is increasing the demand for the healthcare data monetization solutions market.
The global arterial cannula market size was estimated at around USD 33.80 million in 2024 and is expected to exceed around USD 54.12 million by 2034, growing at a CAGR of 4.82% from 2025 to 2034. The global arterial cannula market growth is attributed to the increasing prevalence of chronic diseases.
The global non-opioid pain patches market size was accounted for USD 991.63 million in 2024 and is expected to exceed around USD 1,816.48 million by 2034, growing at a CAGR of 6.24% from 2025 to 2034. The non-opioid pain patches market growth is attributed to the increasing demand for safer, non-opioid alternatives for pain management amid growing concerns over opioid-related risks.
The global healthcare business collaboration tools market size was worth around USD 32.53 billion in 2024 and is expected to hit around USD 266.99 billion by 2034, growing at a CAGR of 23.43% from 2025 to 2034. The growth in the healthcare business collaboration tools market is because of factors such as increased demand for remote business services and healthcare services, increased use of digital technologies, and the demand for patient care management.
The global human chorionic gonadotropin market size was calculated at USD 2.15 billion in 2024 and is predicted to reach around USD 2.94 billion by 2034, expanding at a CAGR of 3.20% from 2025 to 2034. The human chorionic gonadotropin market is driven by the rising prevalence of infertility and increased demand for assisted reproductive technologies (ART) such as in-vitro fertilization (IVF).
The global cannula market size was calculated at USD 189.94 million in 2024 and is predicted to reach around USD 396.60 million by 2034, expanding at a CAGR of 7.64% from 2025 to 2034. The cannula market is driven by the increasing prevalence of minimally invasive surgeries.
The global surgical snare market size accounted for USD 2.27 billion in 2024 and is expected to exceed around USD 3.34 billion by 2034, growing at a CAGR of 3.96% from 2024 to 2034. The surgical snare market is driven by the increasing incidence of gastrointestinal (GI) conditions that necessitate minimally invasive operations like polypectomy and tumor removal, such as colorectal cancer and polyps.
The global post-traumatic stress disorder treatment market size is calculated at USD 2.28 billion in 2024 and is predicted to reach around USD 3.42 billion by 2034, expanding at a CAGR of 4.14% from 2024 to 2034. The post-traumatic stress disorder treatment market is driven by the growing understanding and acceptance of mental health issues.
The global spinal imaging market size is worth around USD 2.09 billion in 2024 and is anticipated to reach around USD 3.49 billion by 2034, growing at a CAGR of 5.23% from 2024 to 2034. The spinal imaging market is driven by the growing need for sophisticated diagnostic instruments like MRIs, CT scans, and X-rays to enable precise diagnosis and treatment planning due to the rising incidence of spinal illnesses like degenerative disc disease, spinal stenosis, and ruptured discs.
The global ureteral stents market size accounted for USD 575.54 million in 2024 and is expected to exceed around USD 1,128.19 million by 2034, growing at a CAGR of 6.96% from 2024 to 2034. A growing incidence of UTSDs, including kidney stones and obstructions, a growing geriatric population, technological innovations, and awareness amongst patients add to the ureteral stents market growth rate.
The global oral vaccine market size accounted for USD 3.87 billion in 2024 and is expected to exceed around USD 9.62 billion by 2034, growing at a CAGR of 9.54% from 2024 to 2034. The rising demand for oral vaccine market is attributable to the need for safer, easier-to-administrate, and more affordable vaccines than injectable vaccines.
The global fusion biopsy market size is calculated at USD 738.94 million in 2024 and is anticipated to reach around USD 1,690.87 million by 2034, expanding at a CAGR of 8.63% from 2024 to 2034. The increasing incidence of prostate cancer worldwide is the key factor driving the fusion biopsy market growth. Advancements in molecular profiling, coupled with the development of technology, can fuel market growth further.
The global vaccine adjuvants market size accounted for USD 1.73 billion in 2024 and is expected to exceed around USD 2.18 billion by 2034, growing at a CAGR of 2.33% from 2024 to 2034. The increasing adoption of the vaccine adjuvants market is as it is an essential component of vaccines in enhancing both immune response and efficacy.
The global lipid nanoparticles market size is worth around USD 1,002.63 million in 2024 and is anticipated to reach around USD 3,694.21 million by 2034, growing at a CAGR of 13.93% from 2024 to 2034. The lipid nanoparticles market is driven by the developments in mRNA therapies as well as the rise in chronic illnesses like cancer and heart disease.
The global medical imaging workstations market size is calculated at USD 9.40 billion in 2024 and is predicted to reach around USD 16.73 billion by 2034, expanding at a CAGR of 5.94% from 2024 to 2034. The medical imaging workstations market is rapidly growing because of the development in techniques related to imaging, the increasing rates of chronic diseases, the increased aging population, AI in imaging, telemedicine, upgrades in healthcare facilities, and the increased spending on healthcare demands for better diagnostic tools.
The global shingles vaccine market size is calculated at USD 4.94 billion in 2024 and is predicted to reach around USD 20.57 billion by 2034, expanding at a CAGR of 15.34% from 2024 to 2034. The increased risks of shingles in the elderly population are the key factors driving the growth of the market. Also, developments in healthcare policies in emerging markets coupled with the increasing shift towards innovative recombinant vaccines are expected to fuel the shingles vaccine market growth further.
The global portable ultrasound bladder scanner market size is worth around USD 281.84 million in 2024 and is anticipated to reach around USD 415.19 million by 2034, growing at a CAGR of 3.95% from 2024 to 2034. The increasing prevalence of urological diseases like urinary infections & incontinence, and bladder cancers are driving the portable ultrasound bladder scanner market. Additionally, increased demand for point-of-care diagnostics is contributing to the market expansion. With the rising adoption of cutting-edge medical devices in healthcare, the market is expected to boost in the forecast period.
The global automated microscopy market size accounted for USD 8.09 billion in 2024 and is expected to exceed around USD 15.08 billion by 2034, growing at a CAGR of 6.43% from 2024 to 2034. The automated microscopy market is driven by the growing need in the healthcare industry for precise and effective diagnostics.
The global analytical standards market size is calculated at USD 1.46 billion in 2024 and is predicted to reach around USD 2.77 billion by 2034, expanding at a CAGR of 6.60% from 2024 to 2034. Rising demand for testing in, environmental monitoring and pharmaceuticals is the key factor driving the growth of the market. Also, stringent regulations imposed by the government across the globe coupled with technological advancements can fuel market growth further.
The global dental tourism market size is worth around USD 13.35 billion in 2024 and is anticipated to reach around USD 97.93 billion by 2034, growing at a CAGR of 22.05% from 2024 to 2034. The demand for dental tourism is rising due to the expansion of the dental infrastructure in developing countries, which provides treatments at lower costs. This is attracting significant consumers from all around the world.
The global molecular biology enzymes, reagents, and kits market size is calculated at USD 25.24 billion in 2024 and is predicted to reach around USD 63.58 billion by 2034, expanding at a CAGR of 9.68% from 2024 to 2034. The molecular biology enzymes, reagents, and kits market is rising along with the increased genomic application, the growing need for molecular diagnostics, expectations for molecular personalized medicine, greater investment in research and development, and innovations in next-generation sequencing and automatization.
The global group life insurance market size is worth around USD 148.72 billion in 2024 and is expected to hit around USD 405.10 billion by 2034, growing at a notable CAGR of 10.54% from 2024 to 2034. The group life insurance market offers a common employee benefit to fulfill the needs of insured beneficiaries in case of emergency while being part of the organization.
The global dental diamond burs market size accounted for USD 2.67 billion in 2024 and is expected to exceed USD 3.71 billion by 2034, growing at a CAGR of 3.36% from 2024 to 2034. Growing demands for dental implants are driving the growth of the dental diamond burs market. Additionally, the rising adoption of cosmetic dentistry expands market success. A growing middle-class population and the availability of disposable income are expected to boost the market in the forecast period.
The global neuropathic pain market size is worth around USD 7.97 billion in 2024 and is expected to hit around USD 16.79 billion by 2034, growing at a CAGR of 7.73% from 2024 to 2034. The growing burden of neuropathic pain among patients suffering from chronic diseases is the key factor driving the neuropathic pain market growth. Also, an increase in demand for neuropathic treatment drugs coupled with the rise in government initiatives can fuel market growth further.
The U.S. pharmaceutical CDMO market size accounted for USD 40.52 billion in 2024 and is expected to exceed around USD 83.25 billion by 2034, growing at a CAGR of 7.50% from 2024 to 2034. The U.S. pharmaceutical CDMO market is driven by the growing need for biosimilars and biologics. Pharmaceutical businesses depend on CDMOs to supply the specialized knowledge, advanced manufacturing capabilities, and regulatory compliance needed for these complex medicines as they invest more and more in biologic therapies, such as vaccines, and monoclonal antibodies.
The global extraoral imaging market size accounted for USD 936.61 million in 2024 and is expected to exceed around USD 1,901.83 million by 2034, growing at a CAGR of 7.34% from 2024 to 2034. Advancements in imaging technologies are the key factor driving the growth of the market. Also, the rising incidence of dental disorders coupled with the increasing need for reliable imaging platforms can fuel the extraoral imaging market growth shortly.
The global microencapsulation market size is worth around USD 14.47 billion in 2024 and is expected to hit around USD 38.98 billion by 2034, growing at a CAGR of 10.42% from 2024 to 2034. The increased attention around microencapsulation technology is the key factor driving the growth of the microencapsulation market. Also, benefits related to microencapsulation coupled with the technology's application offer can fuel market growth further.
The global 3D printing in medical applications market size is worth around USD 4.13 billion in 2024 and is anticipated to reach around USD 19.74 billion by 2034, growing at a CAGR of 16.94% from 2024 to 2034. The 3D printing in medical applications market is driven by the growing need for individualized medical care, including prosthetics and implants made for each patient.
The global dental services organization market size is calculated at USD 163.89 billion in 2024 and is anticipated to reach around USD 830.56 billion by 2034, growing at a CAGR of 17.62% from 2024 to 2034.b The dental services organization market is driven by the increasing need, due to economies of scale, for affordable dental treatment.
The global saliva collection and diagnostics market size is calculated at USD 819.67 million in 2024 and is predicted to reach around USD 1,305.24 million by 2034, expanding at a CAGR of 4.76% from 2024 to 2034. Increasing demand for quick diagnoses of diseases is the key factor driving the growth of the saliva collection and diagnostics market. Also, rising public awareness regarding safe diagnostic solutions coupled with the innovations in infant sample collection technology, can fuel market growth further.
The global ultrasound transducer market size is worth around USD 3.80 billion in 2024 and is anticipated to reach around USD 5.23 billion by 2034, growing at a CAGR of 3.24% from 2024 to 2034. The demand for the ultrasound transducer market is growing due to their rising use in medical fields like diagnostics and surgeries. The increasing prevalence of medical conditions also contributes to market growth.
The global dental 3D printing devices market size is worth around USD 10.70 billion in 2024 and is anticipated to reach around USD 63.12 billion by 2034, growing at a double-digit CAGR of 19.42% from 2024 to 2034. The growth of the dental 3D printing devices market is attributed to a potential footprint and the combination of state-of-art technology. The development and designs of advanced products, including delivery positioning, advanced fabrication to provide an aesthetic look, and invisible aligners, are the major factors increasing the adoption and demand for dental 3D printers.
The global bioburden testing market size is calculated at USD 1.51 billion in 2024 and is predicted to reach around USD 5.80 billion by 2034, expanding at a CAGR of 14.40% from 2024 to 2034. The demand for the bioburden testing market is rising due to concerns regarding food quality. Companies are adopting these procedures which ensure the food quality that also gains the public trust and increases the reliability.
The global halal empty capsules market size accounted for USD 1.28 billion in 2024 and is expected to exceed USD 2.16 billion by 2034, growing at a CAGR of 5.43% from 2024 to 2034. Increasing demand for halal-certified products in the pharmaceutical sector is the key factor driving the growth of the halal empty capsules market. Also, rising consumer preference for plant-based capsules coupled with the key players' focus on expanding production facilities across the globe can fuel market growth further.
The global dental preventive supplies market size accounted for USD 5.98 billion in 2024 and is expected to exceed around USD 8.96 billion by 2034, growing at a CAGR of 4.13% from 2024 to 2034. The growth of the global dental preventive supplies market is driven by increased production and supply of effective dental products by leading companies. With the growing prevalence of oral diseases worldwide, the awareness about preventive care is rising, which further drives the market growth.
The global structural heart imaging market size accounted for USD 9.44 billion in 2024 and is expected to exceed around USD 16.76 billion by 2034, growing at a CAGR of 5.91% from 2024 to 2034. The increasing incidence of various congenital diseases is the key factor driving the growth of the structural heart imaging market. Also, the rise in lifestyle-related diseases coupled with the growing prevalence of cardiac disorders can fuel market growth further.
The global general anesthesia drugs market size is calculated at USD 5.40 billion in 2024 and is predicted to reach around USD 7.79 billion by 2034, expanding at a CAGR of 3.72% from 2024 to 2034. The general anesthesia drugs market is driven by the rising prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and cancer.
The global body contouring devices market size is worth around USD 1.75 billion in 2024 and is expected to hit around USD 6.67 billion by 2034, growing at a CAGR of 14.32% from 2024 to 2034. The rising demand for eliminating fat through a non-invasive technique and feeling healthy naturally is increasing the adoption of body contouring devices in the body contouring devices market.
The global pharmaceutical CRO market size is calculated at USD 44.58 billion in 2024 and is anticipated to reach around USD 91.20 billion by 2034, expanding at a CAGR of 7.42% from 2024 to 2034. The increasing burden of chronic disease in the worldwide population is driving the demand for the research and development process for drug discovery and development that is driving the growth of the market.
The global sterilization services market size is estimated at USD 5.60 billion in 2024 and is anticipated to reach around USD 10.64 billion by 2034, expanding at a CAGR of 6.62% from 2024 to 2034. The increasing demand for sterilization services by several leading industries, such as healthcare, pharmaceutical, and other consumer industries, is accelerating the growth of the market.
The global lung cancer diagnostics market size accounted for USD 5.02 billion in 2024 and is anticipated to reach around USD 9.45 billion by 2034, expanding at a CAGR of 6.53% between 2024 and 2034. surge in active smokers and unhealthy lifestyles is the key factor driving the growth of the market. Also, the increasing demand for innovative diagnostic tools and services in imaging technologies like CT scans can fuel market growth further.
The global photomedicine devices and technologies market size accounted for USD 4.06 billion in 2024 and is anticipated to reach around USD 11.44 billion by 2034, expanding at a CAGR of 10.92% between 2024 and 2034. Rising cases of vision correction surgeries are the key factor driving the photomedicine devices and technologies market. The rising prevalence of cancer, along with the R&D initiatives by market players.
The global intravenous (IV) hydration therapy market size is calculated at USD 2.71 billion in 2024 and is projected to surpass around USD 5.84 billion by 2034, expanding at a CAGR of 7.98% from 2024 to 2034. The intravenous (IV) hydration therapy market is driven by the rising demand for preventative and wellness services.
The global contraceptive drugs and devices market size is calculated at USD 31.40 billion in 2024 and is projected to surpass around USD 55.86 billion by 2034, expanding at a CAGR of 5.93% from 2024 to 2034. The increase in the number of sexually transmitted diseases and unintended pregnancies is expected to drive market growth. Government efforts to spread awareness regarding contraception are also driving market growth. In addition, increasing government policies on controlling the population are further anticipated to enhance the contraceptive drugs and devices market growth.
The global microelectronic medical implants market size is calculated at USD 34.56 billion in 2024 and is projected to surpass around USD 65.60 billion by 2034, expanding at a CAGR of 6.62% from 2024 to 2034. The microelectronic medical implants market growth is attributed to the increasing prevalence of chronic diseases, technological advancements in implant design, and rising healthcare expenditures globally.
The global histoplasmosis treatment market size accounted for USD 2.27 billion in 2024 and is projected to reach around USD 5.38 billion by 2034, growing at a CAGR of 9.25% from 2024 to 2034. The histoplasmosis treatment market is driven by the rising prevalence of histoplasmosis.
The global bowel stimulators market size is calculated at USD 1.11 billion in 2024 and is projected to surpass around USD 2.15 billion by 2034, expanding at a CAGR of 6.83% from 2024 to 2034. The bowel stimulators market is driven by the growing aging population.
The U.S. retail clinics market size is calculated at USD 3.86 billion in 2024 and is projected to surpass around USD 8.45 billion by 2034, expanding at a CAGR of 8.15% from 2024 to 2034. The rapid evaluation of the healthcare industry in the United States and the demand for faster treatment providing healthcare solutions drive the growth of the U.S. retail clinic market.
The global dental market size is calculated at USD 39.66 billion in 2024 and is projected to surpass around USD 121.22 billion by 2034, expanding at a CAGR of 11.82% from 2024 to 2034. The dental market is rapidly rising due to the increasing people’s awareness of oral health, the elderly population, advancement in technologies, demand for aesthetic dental procedures, and an increased number of dental practices, and services.
The global emergency general surgery services market size is worth around USD 22.87 billion in 2024 and is predicted to surpass around USD 40.03 billion by 2034, growing at a CAGR of 5.76% from 2024 to 2034. The emergency general surgery services market is set to rise due to increasing rates of acute surgical illnesses, increasing urbanization, development in medical technology, and better health systems.
The global breast ultrasound market size is calculated at USD 2.30 billion in 2024 and is projected to surpass around USD 8.67 billion by 2034, expanding at a CAGR of 14.21% from 2024 to 2034. The rising prevalence of breast cancer is the key factor driving market growth. The increase in demand for breast ultrasound, along with technological advancements, can fuel market growth further.
The global sinusitis treatment market size is calculated at USD 2.4 billion in 2024 and is anticipated to reach around USD 4.22 billion by 2034, expanding at a CAGR of 5.82% from 2024 to 2034. Increasing prevalence of the condition is the key factor driving the growth of the market. Also, the growing need for timely diagnosis, along with the growing demand for better treatment options, is expected to fuel market growth shortly.
The global egg freezing and embryo banking market size accounted for USD 5.41 billion in 2024 and is anticipated to be worth around USD 25.63 billion by 2034, registering at a double-digit CAGR of 16.83% from 2024 to 2034. The increasing cases of infertility cases, late pregnancies, and other lifestyle factors are contributing to the growth of the market.
The global human osteoblasts market size is calculated at USD 48.74 million in 2024 and is projected to hit around USD 90.71 million by 2034, expanding at a CAGR of 6.41% from 2024 to 2034. The human osteoblasts market is driven by the rapidly growing geriatric population worldwide.
The global telemedicine cart market size is worth around USD 1,088.34 million in 2024 and is anticipated to reach around USD 4,218.9 million by 2034, growing at a CAGR of 14.51% from 2024 to 2034. The telemedicine cart market is driven by advancements in audio and video technologies that guarantee that patients and healthcare professionals can communicate clearly and effectively. Strong security measures safeguard data integrity and patient privacy. Telemedicine carts can easily interface with current EHR systems, making patient data access and management more efficient.
The global psoriasis biosimilars market size is calculated at USD 9.41 billion in 2024 and is projected to surpass around USD 27.22 billion by 2034, expanding at a CAGR of 11.21% from 2024 to 2034.
The global critical care drugs market size is calculated at USD 1.16 billion in 2024 and is projected to hit around USD 1.91 billion by 2034, expanding at a CAGR of 5.12% from 2024 to 2034. The critical care drugs market is driven by the world's population is aging quickly, and the prevalence of chronic illnesses and lifestyle-related ailments is rising.
The global dental surgical navigation systems market size accounted for USD 88.03 million in 2024 and is projected to reach around USD 197.5 million by 2034, growing at a CAGR of 8.41% from 2024 to 2034. The dental surgical navigation systems market is driven by the rise in interest in minimally invasive dental procedures.
The global cell banking outsourcing market size is calculated at USD 14.38 billion in 2024 and is projected to surpass around USD 43.59 billion by 2034, expanding at a CAGR of 11.72% from 2024 to 2034. The rising advancement of cryopreservation and cell bank preparation methodologies is the key factor to drive the cell banking outsourcing market growth.
The global acute wound care market size is calculated at USD 9.35 billion in 2024 and is projected to surpass around USD 14.27 billion by 2034, expanding at a CAGR of 4.32% from 2024 to 2034. The rising incidences of injuries through accidents and falls are one of the major factors driving the market growth. These rising cases are leading towards the adoption of acute wound care services that might help in providing healthcare services to patients.
The global retinal vasculitis treatment market size is calculated at USD 544.66 million in 2024 and is projected to surpass around USD 949.04 million by 2034, expanding at a CAGR of 5.71% from 2024 to 2034. The retinal vasculitis treatment market is driven by the increasing number of people with systemic autoimmune disorders.
The global renal biomarkers market size is calculated at USD 1.62 billion in 2024 and is projected to reach around USD 3.57 billion by 2034, expanding at a CAGR of 8.21% from 2024 to 2034. The renal biomarkers market is driven by rising demand for the evaluation of kidney function to determine the severity and nature of kidney injury.
The global viral clearance market size is calculated at USD 0.93 billion in 2024 and is projected to surpass around USD 6.78 billion by 2034, expanding at a CAGR of 22.01% from 2024 to 2034. The viral clearance market is driven by the growing demand for biopharmaceutical products.
The global dental panoramic radiography market size is calculated at USD 279.74 million in 2024 and is projected to surpass around USD 422.92 million by 2034, expanding at a CAGR of 4.22% from 2024 to 2034. The dental panoramic radiography market is driven by the rising incidence of periodontitis and implant dentistry.
The global newborn screening market size accounted for USD 909.18 million in 2024 and is expected to reach around USD 1,882.59 million by 2034, with a CAGR of 7.55% from 2024 to 2034. The rapid increase in the number of neonatal population is playing a crucial role in the demand for the newborn screening market. This helps in early intervention by examining them for rare illnesses and early detection of any disability.
The global outbound medical tourism services market size accounted for USD 247.38 billion in 2024 and is predicted to surpass around USD 755.39 billion by 2034, growing at a CAGR of 11.81% from 2024 to 2034.
The global neurological biomarkers market size is calculated at USD 9.14 billion in 2024 and is projected to surpass around USD 30.77 billion by 2034, expanding at a CAGR of 12.90% from 2024 to 2034. The benefits of neurological biomarkers include being used to track brain health by researchers measuring molecules, being helpful in more effective treatments, faster drug development, earlier diagnosis, and being less invasive, which helps the growth of the market.
The global dental braces market size is worth around USD 4.70 billion in 2024 and is anticipated to reach around USD 8.99 billion by 2034, growing at a CAGR of 6.71% over the forecast period 2024 to 2034. The North America dental braces market size reached USD 770 million in 2023. The dental braces market is driven by the increasing demand for aesthetic dental treatments. Integration of 3D printing, digital scans, and AI for customized braces is making treatments more precise, efficient, and attractive to patients.
The global albumin market size is worth around USD 6.74 billion in 2024 and is anticipated to reach around USD 11.64 billion by 2034, growing at a CAGR of 5.62% over the forecast period 2024 to 2034. The demand for albumin market is driven by increasing demand for albumin in emerging economies, advancements in biotechnology for albumin production, increasing plasma fractionation facilities, and the rising prevalence of chronic diseases that require albumin-based therapies.
The global dental 3D printing market size is worth around USD 3.94 billion in 2024 and is anticipated to reach around USD 41.09 billion by 2034, growing at a solid CAGR of 26.41% over the forecast period 2024 to 2034. The North America dental 3D printing market size reached USD 1.22 billion in 2023. The dental 3D printing market is driven by the quick uptake of digital dentistry and the rising need for individualized dental care.
The global cardiac biomarkers market size is expected to be worth USD 21.20 billion in 2024 and is anticipated to reach around USD 82.99 billion by 2034, growing at a solid CAGR of 14.62% over the forecast period 2024 to 2034. The North America cardiac biomarkers market size reached USD 7.59 billion in 2023. The rising demand for adequate diagnosis and monitoring of heart attack, stroke, or any heart disease is projected to accelerate the growth of the cardiac biomarkers market.
The global trauma fixation devices market size is expected to be valued at USD 8.76 billion in 2024 and is anticipated to reach around USD 13.03 billion by 2034, expanding at a solid CAGR of 4.05% over the forecast period 2024 to 2034. The North America trauma fixation devices market size reached USD 3.96 billion in 2023. The trauma fixation devices market is driven by the growing number of severe injuries. Various factors influence this development, including falls, sports injuries, industrial accidents, and traffic accidents. Fixation devices are necessary for the appropriate healing and rehabilitation of these injuries since they frequently cause fractures, dislocations, and other traumas connected to the bones.
The global aptamers market size is worth around USD 2.91 billion in 2024 and is anticipated to reach around USD 26.23 billion by 2034, growing at a solid CAGR of 24.57% over the forecast period 2024 to 2034. The North America aptamer market size reached USD 1.05 billion in 2023.The increasing prevalence of chronic disorders, growing research and development, and increasing investments drive aptamers market growth.
The global wireless health market size is worth around USD 239.70 billion in 2024 and is anticipated to reach around USD 1,322.02 billion by 2034, growing at a CAGR of 18.62% over the forecast period 2024 to 2034. The North America wireless health market size reached USD 99.01 billion in 2023. The wireless health market is driven by the growing acceptance of fitness trackers, smartwatches, and other wearable technology. It is a significant factor propelling the market for wireless health. These gadgets can track a number of health indicators, including blood pressure, heart rate, sleep patterns, and activity level. This data is helpful for both patients and medical professionals.
The global extruded plastics market size is worth around USD 10.69 billion in 2024 and is anticipated to reach around USD 17.47 billion by 2034, growing at CAGR of 5.03% over the forecast period 2024 to 2034. The imaging agents market growth is attributed to the development in providing information about structural or disease-related changes.
The global sternal closure systems market size is worth around USD 2.81 billion in 2024 and is anticipated to reach around USD 4.77 billion by 2034, growing at a solid CAGR of 5.42% over the forecast period 2024 to 2034. The North America sternal closure systems market size reached USD 910 million in 2023. Increasing cardiovascular diseases across the globe are turning into fatal conditions that need to be treated precisely; along with that, accidental injuries to the sterna affecting the quality of patients' lives after surgeries are the major cause driving the sternal closure systems market globally.
The global glaucoma surgery devices market size is worth around USD 1.78 billion in 2024 and is anticipated to reach around USD 2.79 billion by 2034, growing at a CAGR of 4.62% over the forecast period 2024 to 2034. The glaucoma surgery devices market is experiencing growth due to factors like increasing prevalence, rising geriatric populations, advancement in technology, and rising awareness about glaucoma.
The global syringes market size is worth around USD 24.59 billion in 2024 and is anticipated to reach around USD 59.39 billion by 2034, growing at a solid CAGR of 9.22% over the forecast period 2024 to 2034. The rising prevalence of chronic diseases and the need for effective drug delivery methods are the key drivers of the syringes market.
The global tangential flow filtration market size is worth around USD 4.53 billion in 2024 and is anticipated to reach around USD 7.33 billion by 2034, growing at a solid CAGR of 4.92% over the forecast period 2024 to 2034. The North America tangential flow filtration market size reached USD 960 million in 2023. The shift towards personalized medicine and complex biologic therapies has fueled investments in TFF technologies and is projected to accelerate the growth of the tangential flow filtration market during the forecast period.
The global radioimmunotherapy market size accounted for USD 2.68 billion in 2024 and is predicted to surpass around USD 12.70 billion by 2034, growing at a CAGR of 16.85% during the forecast period 2024 to 2034. The radioimmunotherapy market growth is attributed to increasing demand for advanced cancer treatments.
The global microtome market size is worth around USD 162.18 billion in 2024 and is anticipated to reach around USD 302.16 billion by 2034, growing at a CAGR of 6.42% over the forecast period 2024 to 2034. The North America microtome market size reached USD 65.53 billion in 2023. Microtomes help cut biological specimens into thin slices, and different types of microtomes carry different benefits. To obtain thin slices of frozen specimens, freezing microtomes, and cryo-microtomes are used, and to obtain ultrathin slices of tissue specimens, an ultramicrotome is used, etc. These factors help to the growth of the market.
The global radiation protection market size is worth around USD 1.99 billion in 2024 and is anticipated to reach around USD 3.19 billion by 2034, growing at a CAGR of 4.81% over the forecast period 2024 to 2034.
The global intravascular imaging market size is worth around USD 411.37 million in 2024 and is anticipated to reach around USD 697.37 million by 2034, growing at a CAGR of 5.42% over the forecast period 2024 to 2034. Increased usage of intravascular imaging modalities is expected to boost intravascular imaging market growth.
The global neonatal infant care market size is worth around USD 3.39 billion in 2024 and is anticipated to reach around USD 6.70 billion by 2034, growing at a CAGR of 7.04% over the forecast period 2024 to 2034. The North America neonatal infant care market size reached USD 1.23 billion in 2023. The neonatal infant care market is driven as premature babies frequently need specialized care, there is a greater need for neonatal infant care goods and services. Improving mother and child health, especially newborn care, is a priority for governments and healthcare institutions.
The global HIV Drugs market size is worth around USD 36.22 billion in 2024 and is anticipated to reach around USD 66.16 billion by 2034, growing at a CAGR of 6.21% over the forecast period 2024 to 2034. The North America HIV drugs market size reached USD 15.69 billion in 2023. The rising incidence of HIV cases and increasing resistance to existing therapies is pushing federal and private investment in the development of new therapies for HIV. These factors are driving growth in the HIV drugs market.
The global liposome drug delivery market size is expected to be worth USD 5.59 billion in 2024 and is anticipated to reach around USD 13.12 billion by 2034, growing at a CAGR of 8.91% over the forecast period 2024 to 2034. The rising healthcare infrastructure and the increasing use of liposome drug delivery method in the various disease such as cancer, skin infraction and other infectious disease are driving the growth of the market.
The global ophthalmic viscosurgical devices (OVD) market size is expected to be worth USD 543.28 million in 2024 and is anticipated to reach around USD 806.50 million by 2034, growing at a solid CAGR of 4.03% over the forecast period 2024 to 2034.The ophthalmic viscosurgical devices (OVD) market is driven by the advancement of cutting-edge surgical procedures, including advanced vitreoretinal surgery and femtosecond laser cataract surgery, drives the need for OVDs with qualities. To ensure the best possible surgical results, these devices must be specifically designed to fulfill the demands of these specific procedures.
The global cancer IVD market size is expected to be worth USD 19.45 billion in 2024 and is anticipated to reach around USD 34.97 billion by 2034, growing at a solid CAGR of 6.04% over the forecast period 2024 to 2034. The North America cancer IVD market size reached USD 6.60 billion in 2023. The rising cancer incidences, advancement of technologies, enhancement in the healthcare sector, and increased awareness among patients drive the market growth.
The global veterinary Imaging market size is expected to be worth USD 1.96 billion in 2024 and is anticipated to reach around USD 3.86 billion by 2034, growing at a CAGR of 7.02% over the forecast period 2024 to 2034.
The global sterility indicators market size is expected to worth USD 1.24 billion in 2024 and is anticipated to reach around USD 4.02 billion by 2034, growing at a solid CAGR of 12.51% over the forecast period 2024 to 2034. The North America sterility indicators market size reached USD 390 million in 2023. The sterility indicators market is increasing due to enhancements in healthcare organizations, the growth and development of the medical device industry, increased awareness for infection control, and government regulations.
The global neonatal ventilators market size is expected to worth USD 457.84 million in 2024 and is anticipated to reach around USD 910.80 million by 2034, growing at a CAGR of 7.12% over the forecast period 2024 to 2034.
The global intrauterine devices market size is expected to be worth USD 6.48 billion in 2024 and is anticipated to reach around USD 9.29 billion by 2034, growing at a CAGR of 3.67% over the forecast period 2024 to 2034.
The global mice model market size is expected to be valued at USD 10.78 billion in 2024 and is anticipated to reach around USD 19.36 billion by 2034, expanding at a solid CAGR of 6.03% over the forecast period 2024 to 2034. The North America mice model market size reached USD 8.24 billion in 2023. The increasing gene editing tools advancements, increased humanized mice model demands, human and mice physiological similarities, increasing personalized medicine consumption in developed and developing countries, etc. contribute to the growth of the market.
The global atrial fibrillation drugs market size is expected to be valued at USD 15.59 billion in 2024 and is anticipated to reach around USD 20.99 billion by 2034, expanding at a solid CAGR of 3.02% over the forecast period 2024 to 2034. The North America atrial fibrillation drugs market size reached USD 25.88 billion in 2023. The increasing demand is due to high incidences of AF, a growing population of elderly, an improved health care system, and better diagnosis and management of the disease are driving the atrial fibrillation drugs market.
The global biologics CDMO market size was estimated at USD 21.96 billion in 2024 and is anticipated to reach around USD 92.37 billion by 2034, growing at a solid CAGR of 15.45% from 2025 to 2034.
The global pressure monitoring market size is projected to be worth around USD 28.69 billion by 2034 from USD 12.78 billion in 2024, at a CAGR of 8.42% from 2024 to 2034. The rising prevalence of chronic diseases, such as hypertension and cardiovascular diseases, is the key factor driving pressure monitoring market growth. The increasing population of senior people can fuel market growth further.
The global medical gas equipment market size is anticipated to reach around USD 5.94 billion by 2034 from USD 2.79 billion in 2024, at a CAGR of 7.83% from 2024 to 2034. The North America medical gas equipment market size reached USD 1.11 billion in 2023. The benefits of medical gas equipment include environmental considerations, compliance with standards, patient comfort, space utilization, cost-effectiveness, convenience and efficiency, safety, etc., contributing to the growth of the market.
The global medical health screening market size is projected to be worth around USD 48.07 billion by 2034 from USD 28.09 billion in 2024, at a CAGR of 5.52% from 2024 to 2034. The North America medical health screening market size reached USD 9.58 billion in 2023. The rising health geriatric population is contributing to the medical health screening market growth.
The U.S. ambulatory surgical center market size is projected to be reach around USD 55.75 billion by 2033 from USD 41.13 billion in 2024, at a CAGR of 3% from 2024 to 2033. The U.S. ambulatory surgical center market is driven by the surgery moving from hospitals to these facilities.
The global lung stent market size is projected to be worth around USD 629.72 million by 2034 from USD 211.46 million in 2024, at a CAGR of 11.53% from 2024 to 2034. The North America lung stent market size reached USD 92.90 million in 2023 The rising investment by private and public organizations for the development of the non-vascular stent is driving the growth of the market. The growing number of lung-related disorders is increasing the demand for lung stents.
The global left atrial appendage closure devices market size is projected to be worth around USD 7.01 billion by 2034 from USD 1.87 billion in 2024, at a CAGR of 14.12% from 2024 to 2034. The North America left atrial appendage closure devices market size reached USD 720 million in 2023. The rising prevalence of atrial fibrillation and rising government initiatives contribute to the growth of the market. The growing technological advancement is also promoting the growth of the market.
The global in-vitro colorectal cancer screening tests market size is projected to be worth around USD 1,310 million by 2034 from USD 970 million in 2024, at a CAGR of 3.06% from 2024 to 2034. The North America in-vitro colorectal cancer screening tests market size reached USD 410 million in 2023. The in-vitro colorectal cancer screening tests market growth is attributed to the increasing incidence of colorectal cancer.
The global health intelligent virtual assistant market size is projected to be worth around USD 4,680.01 million by 2034 from USD 513.91 million in 2024, at a CAGR of 24.72% from 2024 to 2034. The North America health intelligent virtual assistant market size reached USD 160.70 million in 2023. Organizations are also adopting technologies that help ensure a smooth patient experience. These advancements are crucial in enhancing the interaction between professionals and patients.
The global surrogacy market size is projected to be worth around USD 195.97 billion by 2034 from USD 21.85 billion in 2024, at a CAGR of 24.53% from 2024 to 2034. The surrogacy market is driven by the growing rates of infertility. With many couples finding it difficult to conceive naturally, surrogacy is a potential option. Several factors, including delayed childbirth, lifestyle decisions, and health issues influence this tendency. Surrogacy drives the market in certain areas since it provides surrogate mothers with a sizable cash opportunity.
The global mobile pet care market size is projected to be worth around USD 1,625.4 million by 2034 from USD 749.40 million in 2024, at a CAGR of 8.05% from 2024 to 2034. A rise in pet adoption and humanization and increased consumer spending on pet care and grooming are driving growth in the mobile pet care market.
The global artificial organs and bionics market size is projected to be worth around USD 100.31 billion by 2034 from USD 41.15 billion in 2024, at a CAGR of 9.32% from 2024 to 2034. The North America artificial organs and bionics market size reached USD 17.69 billion in 2023. The key drivers of the artificial organs and bionics market are the increasing number of transplants and the rising number of people waiting for donors.
The global pharmaceutical cold chain packaging market size is projected to be worth around USD 69.55 billion by 2034 from USD 17.46 billion in 2024, at a CAGR of 14.82% from 2024 to 2034. The North America pharmaceutical cold chain packaging market size reached USD 5.17 billion in 2023. Strong cold chain packaging solutions are required to preserve product efficacy due to the increase in the manufacture and distribution of biologics and vaccines that are temperature sensitive. This drives the growth of the pharmaceutical cold chain packaging market.
The global sexual wellness products market size is projected to be worth around USD 52.71 billion by 2034 from USD 25.29 billion in 2024, at a CAGR of 7.62% from 2024 to 2034. The rising development in the healthcare sector is driving the market growth. Also, the growing infertility issue among couples has contributed to the market growth. Additionally, advancements in medical technology have driven the growth of the sexual wellness products market.
The global lacrimal devices market size is projected to be worth around USD 238.24 million by 2034 from USD 165.19 million in 2024, at a CAGR of 3.73% from 2024 to 2034. The North America lacrimal devices market size reached USD 57.33 million in 2023. increasing prevalence of eye disorders, easy procedures for lacrimal treatment, and advanced technologies in lacrimal devices contribute to the growth of the market.
The global lyophilization equipment market size is projected to be worth around USD 19.53 billion by 2034 from USD 7.94 billion in 2024, at a CAGR of 9.44% from 2024 to 2034. The North America lyophilization equipment market size reached USD 2.54 billion in 2023. The lyophilization equipment market helps in various industries like biomedical, biotechnology, pharmaceutical, and food processing for various applications. It helps to reduce sample contamination risks, increases reliability and robustness, and simplifies assay setup.
The global healthcare IT outsourcing market size is projected to be worth around USD 150.13 billion by 2034 from USD 74.14 billion in 2024, at a CAGR of 7.31% from 2024 to 2034. The North America healthcare IT outsourcing market size reached USD 39.38 billion in 2023. Increasing digitalization across healthcare system resulting into the need to manage vast amount of data so that to focus on core functionalities like patient centric management are the driving factors for healthcare IT outsourcing market.
The global anti-obesity drugs market size is projected to be worth around USD 55.25 billion by 2034 from USD 5.69 billion in 2024, at a CAGR of 5.53% from 2024 to 2034. The North America anti-obesity drugs market size reached USD 3.04 billion in 2023. The increase in the incidence of obesity has led to a large patient population suffering from debilitating problems, which is the key factor driving the anti-obesity drugs market growth.
The global computer vision in healthcare market size is projected to be worth around USD 53.01 billion by 2034 from USD 2.60 billion in 2024, at a CAGR of 35.21% from 2024 to 2034. The North America computer vision in healthcare market size reached USD 710 million in 2023. Increasing demand for personalized treatments is driving the growth of computer vision in healthcare market.
The global coronary artery bypass graft market size is projected to be worth around USD 35.17 billion by 2034 from USD 14.28 billion in 2024, at a CAGR of 9.43% from 2024 to 2034. The need for the coronary artery bypass graft market is driven by the rise in cardiovascular illnesses worldwide, which frequently necessitate surgical intervention.
The North America diabetic foot ulcer treatment market size is projected to be worth around USD 5.56 billion by 2034 from USD 3.15 billion in 2024, at a CAGR of 5.86% from 2024 to 2034. The rising cases of diabetes, and advanced research and development drive the North America diabetic foot ulcer treatment market. Alongside, the well-established healthcare infrastructure is observed to promote the market’s expansion in the upcoming years.
The global laboratory temperature control units market size is projected to be worth around USD 1,181.90 million by 2034 from USD 657.48 million in 2024, at a CAGR of 6.04% from 2024 to 2034. The increasing research and development activities worldwide contribute to the growth of the market. The growing prevalence of chronic conditions pushes the key players and government institutions to conduct R&D.
The global cell analysis market size is projected to be worth around USD 84.01 billion by 2034 from USD 32.95 billion in 2024, at a CAGR of 9.81% from 2024 to 2034. The growing prevalence of rare diseases around the world has driven the growth of the cell analysis market. Also, the rising number of cloud-based cell analysis services boosts industrial growth. Moreover, the rise in the number of hospitals and clinical settings contributes positively to the market.
The global organ care products market size is projected to be worth around USD 757.90 million by 2034 from USD 174.19 million in 2024, at a CAGR of 15.84% from 2024 to 2034. The North America organ care products market size reached USD 84.21 million in 2023. The rising incidence of organ failure among adults contributes to market growth. Rising awareness about organ donation across the globe is also observed to support the market’s expansion in the upcoming years.
The global pharmaceutical analytical testing market size is projected to be worth around USD 21 billion by 2034 from USD 8.37 billion in 2024, at a CAGR of 8.72% from 2024 to 2034. The North America pharmaceutical analytical testing market size reached USD 3.26 billion in 2023. The pharmaceutical analytical testing market is driven by the major factors such as rising investments in the pharmaceutical industry and booming government support for the same. Alongside, major players are involved in creating sophisticated and advanced testing materials, these factors along with technological innovations will support the market’s growth.
The global medical radiation shielding market size is projected to be worth around USD 3.08 billion by 2034 from USD 1.61 billion in 2024, at a CAGR of 6.7% from 2024 to 2034. The North America medical radiation shielding market size reached USD 570 million in 2023. The medical radiation shielding market is driven by rising investments in the healthcare infrastructure, especially by developing countries such as Asian countries. Additionally, integration of advanced technologies in the market creates potential for the market to grow.
The global disposable surgical devices market size is projected to be worth around USD 13.90 billion by 2034 from USD 6.31 billion in 2024, at a CAGR of 8.22% from 2024 to 2034. The North America disposable surgical devices market size reached USD 1.98 billion in 2023.The disposable surgical devices market is driven by the rising rates of chronic illness.
The global RTLS healthcare market size is projected to be worth around USD 16.02 billion by 2034 from USD 2.88 billion in 2024, at a CAGR of 18.70% from 2024 to 2034. The benefits of RTLS healthcare include increased healthcare quality, reduced expenses by preventive maintenance, improved patient experience, etc. contributing to the growth of the market.
The global vascular access devices market size is projected to be worth around USD 3.36 billion by 2034 from USD 2.02 billion in 2024, at a CAGR of 5.22% from 2024 to 2034. The North America vascular access devices market size reached USD 1.13 billion in 2023. The rising population and the increasing demand for healthcare infrastructure are driving the growth of the market. Sealants
The global stem cell manufacturing market size is projected to be worth around USD 41.45 billion by 2034 from USD 14.18 billion in 2024, at a CAGR of 11.32% from 2024 to 2034. The North America stem cell manufacturing market size reached USD 4.97 billion in 2023. The stem cell manufacturing market is driven by the increasing prevalence of long-term illnesses like diabetes, cancer, and neurological conditions. It is the main factor propelling the market for stem cell production. Promising therapy options for various diseases are provided by stem cell-based therapies, which drive demand for their development and manufacture.
The global angioplasty balloons market size is projected to be worth around USD 3.86 billion by 2034 from USD 2.63 billion in 2024, at a CAGR of 3.92% from 2024 to 2034. The North America angioplasty balloons market size reached USD 1.04 billion in 2023. The increasing prevalence of cardiovascular diseases across the world driving the growth of the market.
The global biochips market size is projected to be worth around USD 41.90 billion by 2034 from USD 12.71 billion in 2024, at a CAGR of 12.67% from 2024 to 2034. The North America biochips market size reached USD 5.53 billion in 2023. The biochips market growth is attributed to increased application in various healthcare settings.
The global clinical risk grouping solution market size is projected to be worth around USD 2,267.76 million by 2034 from USD 760.84 million in 2024, at a CAGR of 11.54% from 2024 to 2034. The North America clinical risk grouping solution market size reached USD 320.60 million in 2023. A global increase in healthcare expenditure due to a rising prevalence of chronic diseases like cancer, diabetes, and cardiovascular conditions and the availability of data due to increased digitization in the healthcare industry is fueling growth in the clinical risk grouping solution market.
The global artificial blood vessels market size is projected to be worth around USD 3.75 billion by 2034 from USD 2.23 billion in 2024, at a CAGR of 5.33% from 2024 to 2034. The demand for the artificial blood vessels market is primarily being boosted by the rising prevalence of various cardiovascular diseases coupled with a rapidly growing geriatric population.
The global neuroprosthetics market size is projected to be worth around USD 62.98 billion by 2034 from USD 14.75 billion in 2024, at a CAGR of 15.62% from 2024 to 2034. The neuroprosthetics market is expanding due to advancements in brain-computer interface technology and increasing demand for enhanced prosthetic functionality.
The global animal growth promoters and performance enhancers market size is predicted to reach around USD 27.63 billion by 2034 from USD 15.68 billion in 2024, at a CAGR of 5.83% from 2024 to 2034. The North America animal growth promoters and performance enhancers market size reached USD 6.37 billion in 2023. The animal growth promoters and performance enhancers market are driven by the animal disease prevalence and antibiotic resistance.
